| Estadio<\/i><\/td>\n | Descripci\u00f3n <\/i><\/td>\n<\/tr>\n| \n | I<\/p>\n<\/td>\n afectaci\u00f3n de una \u00fanica regi\u00f3n ganglionar o estructura linfoide (ej: bazo, timo, anillo Waldeyer)<\/td>\n<\/tr>\n | \n | II<\/p>\n<\/td>\n afectaci\u00f3n de dos o m\u00e1s regiones ganglionares en el mismo lado del diafragma (el mediastino es un s\u00f3lo sitio; los hiliares son uno de cada lado); el n\u00famero de sitios se indica con un subfijo (ej: II3)<\/p>\n | <\/td>\n<\/tr>\n \n | III<\/p>\n III1<\/p>\n III2<\/p>\n<\/td>\n Afectaci\u00f3n de regiones linf\u00e1ticas o estructuras linf\u00e1ticas a ambos lados del diafragma.<\/p>\n | Abdomen superior (esplenico, cel\u00edaco, portal)<\/p>\n Abdomen inferior (paraa\u00f3rtico, mesent\u00e9rico)<\/td>\n<\/tr>\n \n | IV<\/p>\n<\/td>\n Afectaci\u00f3n de sitios extranodales m\u00e1s all\u00e1 de los indicados como E. Afectaci\u00f3n visceral.<\/td>\n<\/tr>\n | \n | A<\/p>\n B<\/p>\n \n X<\/p>\n \n E<\/p>\n CS<\/p>\n PS<\/p>\n<\/td>\n No s\u00edntomas B<\/p>\n | Fiebre, sudoraci\u00f3n nocturna, p\u00e9rdida de peso superior al 10% del peso corporal en los seis meses previos<\/p>\n Enfermedad voluminosa (bulky): ensanchamiento mediast\u00ednico >1\/3 medido a nivel de T5-6, o masa >10cm.<\/p>\n Afectaci\u00f3n de un \u00fanico sitio extranodal contiguo o pr\u00f3ximo a la localizaci\u00f3n nodal conocida<\/p>\n Estadio cl\u00ednico<\/p>\n Estadio patol\u00f3gico<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Fuente: Lister TA, Crowther D, Sutcliffe SB, Glatstein E, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2032s disease: Cotswolds meeting. J Clin Oncol. 1989;7(11):1630-6.<\/p>\n","protected":false},"excerpt":{"rendered":" Estadio Descripci\u00f3n I afectaci\u00f3n de una \u00fanica regi\u00f3n ganglionar o estructura linfoide (ej: bazo, timo, anillo Waldeyer) II afectaci\u00f3n de dos o m\u00e1s regiones ganglionares en el mismo lado del diafragma (el mediastino es un s\u00f3lo sitio; los hiliares son uno de cada lado); el n\u00famero de sitios se indica con un subfijo (ej: II3) … Continue reading “Clasificaci\u00f3n de Cotswolds.”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[9],"tags":[],"class_list":["post-7248","post","type-post","status-publish","format-standard","hentry","category-hematologia"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts\/7248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7248"}],"version-history":[{"count":0,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts\/7248\/revisions"}],"wp:attachment":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} |